Log in to save to my catalogue

Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance...

Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2699703190

Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease

About this item

Full title

Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease

Publisher

London: Nature Publishing Group UK

Journal title

Leukemia, 2022-12, Vol.36 (12), p.2793-2801

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Recently, we defined “CML-like” subtype of BCR::ABL1-positive acute lymphoblastic leukemia (ALL), resembling lymphoid blast crisis of chronic myeloid leukemia (CML). Here we retrospectively analyzed prognostic relevance of minimal residual disease (MRD) and other features in 147 children with BCR::ABL1-positive ALL (diagnosed I/2000–IV/2021, treate...

Alternative Titles

Full title

Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2699703190

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2699703190

Other Identifiers

ISSN

0887-6924

E-ISSN

1476-5551

DOI

10.1038/s41375-022-01668-0

How to access this item